LexaGene anticipates changing the pathogen detection landscape by providing a customizable sample-to-answer instrument that is more rapid and sensitive than anything available to date. Led by experienced management and accomplished scientists, LexaGene aims to transform the way pathogen testing is performed by multi-billion dollar industries such as food safety, veterinary diagnostics, water quality management, aquaculture farming, and more.
- LexaGene’s breakthrough technology was invented by its founder, a lead scientist in developing predecessor instruments adopted by US Government for bio-warfare surveillance and supported by over $20M USD in funding
- $17.8 Billion+ USD market opportunity
- Applicable to multiple multi-billion dollar industries; including food safety testing where recent FDA changes create a market-changing opportunity
- Breakthrough technology with R&D risk mitigated
- Patent protected IP
- Equity structure managed to maximize shareholder value
- Listed on OTCQB as LXXGF and TSX.V as LXG
LexaGene on Fox Biz TV
LexaGene was featured on an episode of Innovations with Ed Begley Jr. which aired on Fox Business Network Saturday 26 August and 9 September @ 5pmET. Learn more about LexaGene by watching the segment.
Introducing the LX6
At a recent conference, LexaGene unveiled our LX6 alpha prototype to get early feedback from the food safety market. Watch Dr. Regan demonstrate the capabilities of LexaGene’s automated pathogen detection system.
LexaGene on The Street
Investment news outlet, The Street, speaks to LexaGene about its revolutionary pathogen detection system, and the company’s plans after the end of November 2017 when phase IV is completed.
We are commercializing the first ‘open-access’ instrument for pathogen detection, allowing users an on-site instrument to target any gene sequence of interest, and return results in about an hour.
Big Bet of 2017
LexaGene declared one of the companies to watch by Pinnacle Digest – a financial newsletter dedicated to bringing its readers insight ‘before the street’ on small cap companies of note.
Food industry news site Food Quality News featured LexaGene in a recent article, interviewing Dr. Jack Regan about the expected applications of the technology in the food processing market and beyond.
Subscribe to Updates
Stay informed about the latest LexaGene developments
LexaGene’s automated instrument quickly detects multiple pathogens with sensitivity and specificity. The platform is anticipated to transform the way food safety, aquaculture pathogen surveillance, water quality monitoring, and other markets get critical answers in less time.
- Fast results
- Can be used by anyone
- Screen for any pathogen
- Extreme sensitivity
- Low cost per test
- Compact design
Latest News and Announcements
15 August 2017 – LexaGene announces the appointment of Manohar Furtado, Ph.D., to the Company’s Board of Directors. Dr. Furtado has extensive experience working in the life sciences industry for over 30 years.
6 July 2017 – LexaGene is pleased to report that the technology for its automated pathogen detection instrument has been successfully de-risked through a series of tests, and an unveiling scheduled.
3 May 2017 – LexaGene is pleased to report that the development of the alpha prototype remains on track and is scheduled to be completed by the end of this November 2017.
21 March 2017 – LexaGene selected to be highlighted on FOX Business Network in an upcoming episode of Innovations with Ed Begley Jr.